J. Joseph

发表

PrabotulinumtoxinA for the Treatment of Moderate-to-Severe Glabellar Lines in Adult Patients With Skin of Color: Post Hoc Analyses of the US Phase III Clinical Study Data

Susan C. Taylor, R. Avelar, P. Grimes, 2020, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Results from Each of Two Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Studies (SAKURA 1 and SAKURA 2)

J. Carruthers, Roman G. Rubio, J. Joseph, 2019, Plastic and reconstructive surgery.

Current aesthetic use of abobotulinumtoxinA in clinical practice: an evidence-based consensus review.

C. Maas, J. Schlessinger, L. Baumann, 2012, Aesthetic surgery journal.

Botulinum Toxin Type A for Glabellar Frown Lines: What Impact of Higher Doses on Outcomes?

S. Cox, J. Joseph, S. Dayan, 2021, Toxins.

High-Dose Neuromodulators: A Roundtable on Making Sense of the Data in Real-World Clinical Practice

J. Carruthers, S. Cox, J. Joseph, 2021, Aesthetic surgery journal. Open forum.

The science and art of dermal fillers for soft-tissue augmentation.

J. Carruthers, R. Narins, J. Joseph, 2009, Journal of drugs in dermatology : JDD.

A double-blind, randomized, multicenter, controlled trial of suspended polymethylmethacrylate microspheres for the correction of atrophic facial acne scars.

L. Baumann, P. Grimes, J. Joseph, 2014, Journal of the American Academy of Dermatology.

A double-blind, randomized, multicenter, controlled trial of suspended polymethylmethacrylate microspheres for the correction of atrophic facial acnescars

L. Baumann, P. Grimes, J. Joseph, 2014 .

Creation and validation of a photonumeric scale for assessment of lip fullness

P. Trévidic, J. Joseph, A. Benedetto, 2022, Journal of cosmetic dermatology.

Safety and Effectiveness of Microfocused Ultrasound With Visualization for the Correction of Moderate to Severe Atrophic Acne Scars

C. Maas, J. Joseph, 2019, Journal of drugs in dermatology : JDD.

Histoacryl. Its use in aesthetic facial plastic surgery.

J. Joseph, F. Kamer, 1989, Archives of otolaryngology--head & neck surgery.

Efficacy and Safety of Two Resilient Hyaluronic Acid Fillers in the Treatment of Moderate-to-Severe Nasolabial Folds: A 64-Week, Prospective, Multicenter, Controlled, Randomized, Double-Blinded, and Within-Subject Study.

J. Dover, G. Monheit, J. Joseph, 2020, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

HYC-24L Demonstrates Greater Effectiveness With Less Pain Than CPM-22.5 for Treatment of Perioral Lines in a Randomized Controlled Trial

N. Sadick, S. Cox, J. Joseph, 2015, Dermatologic Surgery.

The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients

J. Dover, J. Schlessinger, L. Baumann, 2021, Aesthetic surgery journal.

Patient Comfort, Safety, and Effectiveness of Resilient Hyaluronic Acid Fillers Formulated With Different Local Anesthetics

J. Joseph, Stacy R. Smith, L. Eaton, 2022, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Efficacy and Safety of a New Resilient Hyaluronic Acid Filler in the Correction of Moderate-to-Severe Dynamic Perioral Rhytides: A 52-Week Prospective, Multicenter, Controlled, Randomized, Evaluator-Blinded Study

J. Schlessinger, Z. Draelos, J. Joseph, 2021, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Effectiveness and Safety of Large Gel Particle Hyaluronic Acid With Lidocaine for Correction of Midface Volume Deficit or Contour Deficiency

J. Dover, J. Joseph, D. Bank, 2016, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

The Case for Synthetic Injectables.

J. Joseph, 2015, Facial plastic surgery clinics of North America.

Collagenase Clostridium Histolyticum-aaes for the Treatment of Cellulite in Women: Results From Two Phase 3 Randomized, Placebo-Controlled Trials

M. Kaminer, J. Schlessinger, V. Young, 2021, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

REFINE-1, a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial With ATX-101, an Injectable Drug for Submental Fat Reduction

J. Carruthers, J. Joseph, P. Walker, 2016, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Collagenase Clostridium Histolyticum-aaes for Treatment of Cellulite: A Pooled Analysis of Two Phase-3 Trials

M. Kaminer, J. Schlessinger, V. Young, 2022, Plastic and reconstructive surgery. Global open.

Long‐Term Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines: Results From a 36‐Month, Multicenter, Open‐Label Extension Study

J. Dover, J. Schlessinger, G. Monheit, 2014, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Does Increasing the Dose of Abobotulinumtoxina Impact the Duration of Effectiveness for the Treatment of Moderate to Severe Glabellar Lines?

J. Joseph, E. Williams, A. Pontius, 2016, Journal of drugs in dermatology : JDD.

Subject satisfaction and psychological well‐being with escalating abobotulinumtoxinA injection dose for the treatment of moderate to severe glabellar lines

S. Cox, J. Joseph, G. Ablon, 2022, Journal of cosmetic dermatology.

Optimizing Patient Outcomes by Customizing Treatment With Microfocused Ultrasound With Visualization: Gold Standard Consensus Guidelines from an Expert Panel

J. Joseph, Jeremy B Green, J. Green, 2019, Journal of drugs in dermatology : JDD.

Real‐world effectiveness and safety of collagenase clostridium histolyticum‐aaes injections for the treatment of thigh cellulite in women: An open‐label study interim analysis

J. Joseph, S. Shridharani, Genzhou Liu, 2022, Journal of cosmetic dermatology.

Current Concepts in the Use of Bellafill

J. Joseph, L. Eaton, S. Cohen, 2015, Plastic and reconstructive surgery.

Advancing the Care of Post-Acne Scarring: Expert Insights Into New Treatment Options.

C. Jacob, J. Joseph, A. Taub, 2016, Journal of drugs in dermatology : JDD.

Two phase 3, randomized, double-blind, placebo-controlled, multicenter trials to evaluate the efficacy and safety of daxibotulinumtoxinA for injection to treat moderate to severe glabellar lines (SAKURA 1 and 2)

V. Bertucci, N. Solish, Roman G. Rubio, 2018, Journal of the American Academy of Dermatology.

Additional thoughts on the new treatment Kybella.

J. Joseph, Joel L Cohen, Jeremy B Green, 2015, Seminars in cutaneous medicine and surgery.